Incorporating Cone-beam CT into the Treatment Planning for Yttrium-90 Radioembolization

CBCT can provide additional information about tumor and tissue perfusion not currently detectable by DSA or 99mTc MAA imaging, which should optimize 90Y microsphere delivery and reduce nontarget embolization.